Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 3-31-2020 - Ainos, Inc. | exhibit31-1_03312020.htm |
| 10-Q - FORM 10-Q 3-31-2020 - Ainos, Inc. | form10-q_03312020.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Amarillo Biosciences, Inc. on Form 10-Q for the period ended March 31, 2020 as filed with
the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that to the best of his knowledge:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.
|
AMARILLO BIOSCIENCES, INC.
|
|
|
Date: May 15, 2020
|
By: /s/ Stephen T. Chen
Stephen T. Chen, Chairman of the Board,
and Chief Executive Officer
|